Alogliptin: A new dipeptidyl peptidase-4 inhibitor for the management of type 2 diabetes mellitus

Hdl Handle:: http://hdl.handle.net/10144/322484
Title:: Alogliptin: A new dipeptidyl peptidase-4 inhibitor for the management of type 2 diabetes mellitus
Authors:: Ndefo, U A; Okoli, O; Erowele, G
Journal:: American Journal of Health-System Pharmacy
Abstract:: The pharmacology, pharmacodynamics, pharmacokinetics, safety, efficacy, and place in therapy of alogliptin and its combinations for managing type 2 diabetes mellitus are reviewed.
Publisher:: American Society of Health System Pharmacists
Issue Date:: 15-Jan-2014
URI:: http://hdl.handle.net/10144/322484
DOI:: 10.2146/ajhp130131
PubMed ID:: 24375601
Language:: en
ISSN:: 1535-2900

Full metadata record

DC Field	Value	Language
dc.contributor.author	Ndefo, U A	en_GB
dc.contributor.author	Okoli, O	en_GB
dc.contributor.author	Erowele, G	en_GB
dc.date.accessioned	2014-07-05T16:46:21Z	-
dc.date.available	2014-07-05T16:46:21Z	-
dc.date.issued	2014-01-15	-
dc.identifier.citation	Alogliptin: A new dipeptidyl peptidase-4 inhibitor for the management of type 2 diabetes mellitus. 2014, 71 (2):103-9 Am J Health Syst Pharm	en_GB
dc.identifier.issn	1535-2900	-
dc.identifier.pmid	24375601	-
dc.identifier.doi	10.2146/ajhp130131	-
dc.identifier.uri	http://hdl.handle.net/10144/322484	-
dc.description.abstract	The pharmacology, pharmacodynamics, pharmacokinetics, safety, efficacy, and place in therapy of alogliptin and its combinations for managing type 2 diabetes mellitus are reviewed.	en_GB
dc.language.iso	en	en
dc.publisher	American Society of Health System Pharmacists	en_GB
dc.rights	Archived with thanks to American Journal of Health-System Pharmacy (AJHP): Official Journal of the American Society of Health-System Pharmacists	en_GB
dc.subject	Non-communicable diseases	en_GB
dc.subject	Other	en_GB
dc.title	Alogliptin: A new dipeptidyl peptidase-4 inhibitor for the management of type 2 diabetes mellitus	en
dc.identifier.journal	American Journal of Health-System Pharmacy	en_GB